Albany Molecular Research, Inc. (AMRI) broke ground at the construction site of a new 50,000 sq.-ft. R&D center at the Shapoorji Pallonji Biotech Park in Hyderabad, India. The new facility represents the first major expansion of the company’s Hyderabad Research Center, a subsidiary of AMRI. When completed in late 2007, the new R&D center will conduct contract projects in early stage drug discovery research, including custom chemical synthesis and medicinal chemistry. The ...